SXI Life Sciences
7.785,82
PKT
+6,91
PKT
+0,09
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.01.05 | Novartis Buy | Helvea | |
| 27.01.05 | Lonza Buy | Helvea | |
| 03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 25.01.05 | Novartis Buy | Helvea | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 24.01.05 | Novartis Overweight | Prudential Securities | |
| 25.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 21.01.05 | Roche Buy | Sarasin Research | |
| 24.01.05 | Lonza Reduce | Sarasin Research | |
| 24.01.05 | Novartis Neutral | HypoVereinsbank | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 20.01.05 | Novartis Hold | SEB | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 20.01.05 | Novartis Neutral | Sarasin Research | |
| 21.01.05 | Novartis Buy | Helvea | |
| 19.01.05 | Novartis Equal-weight | Morgan Stanley | |
| 19.01.05 | BB Biotech Kaufen | Hamburger Sparkasse | |
| 19.01.05 | Tecan (N) Reduce | Helvea | |
| 19.01.05 | Straumann Accumulate | Helvea | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 18.01.05 | Novartis Buy | AG Edwards | |
| 18.01.05 | Novartis Outperform | Bear Stearns | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Lonza Buy | Helvea | |
| 18.01.05 | Roche Buy | Merrill Lynch | |
| 18.01.05 | Siegfried Neutral | Helvea | |
| 18.01.05 | Novartis Akkumulieren | Independent Research | |
| 18.01.05 | Novartis Buy | Sarasin Research | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 17.01.05 | Lonza Reduce | Sarasin Research | |
| 17.01.05 | Novartis Sector Outperform | Vontobel | |
| 14.01.05 | Novartis Overweight | Lehman Brothers | |
| 14.01.05 | Novartis Kaufen | Helaba Trust |